| __timestamp | Merck & Co., Inc. | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7180000000 | 18516000 |
| Thursday, January 1, 2015 | 6704000000 | 34140000 |
| Friday, January 1, 2016 | 7194000000 | 51872000 |
| Sunday, January 1, 2017 | 9982000000 | 71772000 |
| Monday, January 1, 2018 | 9752000000 | 97501000 |
| Tuesday, January 1, 2019 | 9872000000 | 118590000 |
| Wednesday, January 1, 2020 | 13397000000 | 169802000 |
| Friday, January 1, 2021 | 12245000000 | 192507000 |
| Saturday, January 1, 2022 | 13548000000 | 199563000 |
| Sunday, January 1, 2023 | 30531000000 | 253598000 |
Data in motion
In the ever-evolving pharmaceutical landscape, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Merck & Co., Inc. and Xencor, Inc. have demonstrated contrasting strategies in their R&D allocations. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking in 2023 with a remarkable 30 billion USD, reflecting its commitment to pioneering medical breakthroughs. In contrast, Xencor, Inc., a smaller biotech firm, exhibited a steady yet modest increase in R&D spending, growing by approximately 1,270% over the same period. This disparity highlights the scale and ambition of Merck's operations compared to Xencor's focused approach. As the industry continues to innovate, these investment patterns underscore the diverse strategies companies employ to stay competitive and drive future advancements.
R&D Insights: How Merck & Co., Inc. and argenx SE Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Ascendis Pharma A/S
Merck & Co., Inc. or Halozyme Therapeutics, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Merck & Co., Inc. vs Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Genmab A/S vs Xencor, Inc.
Research and Development: Comparing Key Metrics for Incyte Corporation and Xencor, Inc.
R&D Spending Showdown: TG Therapeutics, Inc. vs Xencor, Inc.
Comparing Innovation Spending: Amicus Therapeutics, Inc. and Xencor, Inc.
Comparing Innovation Spending: Agios Pharmaceuticals, Inc. and Xencor, Inc.
Research and Development Investment: Iovance Biotherapeutics, Inc. vs Xencor, Inc.
Research and Development Expenses Breakdown: Taro Pharmaceutical Industries Ltd. vs Xencor, Inc.